Yankees hitter Alex Rodriguez seems to be dating Anne Wojcicki, the C.E.O. and co-founder of 23andMe start-up, more famous as an ex-wife of Google co-founder Sergey Brin.
Last year Rodriguez broke up with his ex, former professional wrestler Torrie Wilson, after three years together. Rodriguez was also once married to Cynthia Scurtis. The marriage lasted for six years and ended after the rumors about Rodriguez’s affairs with Madonna appeared. The couple has two common children, Natasha, 11, and Ella, 7.
According to Page Six, the 40-year-old Yankees, who reportedly had love affairs with Cameron Diaz in 2010 and Kate Hudson in 2009 as well, has decided to depart from his usual type. He has been seeing 42-year-old Wojcicki for more than a month.
They were noticed last month at Vanity Fair’s Super Bowl party in San Francisco. Rodriguez was allegedly in the audience at the Annual Clinical Genetics Meeting, in Tampa, where Wojcicki spoke.
Page Six cites the unknown source: “Alex and Anne are spending time together and have been on a few dates. It is very new. He finds her interesting, inspirational and very smart.”
Remarkably, that Rodriguez has found a women actually richer than himself. After the very public divorce with Google co-founder Sergey Brin, Wojcicki is worth billions.
Wojcicki and Brin divorced in 2013 after eight years together. They have two children from their marriage. When the couple separated, Brin started dating a woman from Google Glass division named Amanda Rosenberg.
Vanity Fair reported at that time that Wojcicki was blindsided by the affair. Now there is no confirmed information whether Brin and his employee are still together. Brin and Wojcicki are officially divorced and are raising their children as a team.
Wojcicki launched billion-dollar personal genomics analytics start-up 23andMe in 2006. The aim of the company is to give consumers personalized genetic information about their health and ancestry. The company takes an active part in genetic research into diseases including Parkinson’s and asthma.
Last year 23andMe raised $115 million in venture-capital funding and its total value reached $1.03 billion. Google and Brin and Fidelity and Johnson & Johnson were among the chief investors.
In 2014, the F.D.A. refused 23andMe to market its DNA-testing kit in the U.S. The agency was concerned that 23andMe could provide inaccurate information about consumers’ health. The company improved and last year presented a new test complying with the F.D.A.’s requirements. Thus it became the first approved direct-to-consumer genetics-testing product.